Pediatric Eye Disease Investigator Group (PEDIG)

Protocol: ATS14 - A Pilot Study to Evaluate Levodopa as Treatment for Residual Amblyopia in 8 to 17 Year Olds
Status: Closed
Start Date: 12/18/2008
End Date: 05/15/2009
Clinical Trial ID: NCT00789672
Public Dataset:  Download


A Pilot Study to Evaluate Levodopa as Treatment for Residual Amblyopia in 8 to 17 Year Olds

Protocol

Objective:
To evaluate levodopa as adjunctive treatment to patching for residual amblyopia (20/50 or worse) in older children and teenagers ages 8 to 17 years old


Publications:

  1. Repka MX, Kraker RT, Beck RW, et. al., Pediatric Eye Disease Investigator Group. Pilot study of levodopa dose as treatment for residual amblyopia in children aged 8 years to younger than 18 years. Arch Ophthalmol 2010;128(9):1215-7.

 



Back

© 2007 -2017 Jaeb Center for Health Research
All forms and reports on this site require Adobe Acrobat Reader. Click HERE to download a free copy of Adobe.
Although JCHR supports various web browsers, only Internet Explorer version 11 is fully tested and validated to function on this site.
This site utilizes popup windows.